Merck KGaA to acquire Millipore

March 8, 2010

LCGC Europe eNews

LCGC Europe eNews-03-05-2010, Volume 0, Issue 0

Merck and Millipore have announced that the two companies have reached an agreement that will see Merck acquire Millipore for around $7.2 billion.

Merck and Millipore have announced that the two companies have reached an agreement that will see Merck acquire Millipore for around $7.2 billion.

“This transaction is very attractive to shareholders, customers and employees of both companies,” said Dr Karl-Ludwig Kley, chairman of the executive board of Merck in a statement.

According to the companies, this transaction will provide them with a significant presence in high-growth segments and an enhanced geographic presence.

The combination of the research and development capabilities of both companies is expected to create a powerful innovation platform for developing cutting-edge technologies that are tailored to the needs of customers.

Dr Kley added, “By combining Millipore’s bioscience and bioprocess knowledge with our own expertise in serving pharma customers, we will be able to unlock value in our chemicals business and transform it into a strong growth driver for Merck. Through this acquisition, we will expand the overall product offering of the Merck Group, using the well-recognized Millipore brand in addition to our own brand.”

For more information on Merck visit www.merck.de and for more on Millipore visit www.millipore.com